← back to search

Li Liang

Hebei Medical University · CN
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Glutathione Transferases and Polymorphisms, RNA modifications and cancer, Cancer Genomics and Diagnostics, and Peptidase Inhibition and Analysis.
h-index
27
citations
2,467
works
126
NIH funding
primary concept
email

Recent publications

A generalizable pathology foundation model using a unified knowledge distillation pretraining framework
Nature Biomedical Engineering 2025cited by 17position: middledoi
A multimodal knowledge-enhanced whole-slide pathology foundation model
Nature Communications 2025cited by 16position: middledoi
Comparison of percutaneous endoscopic lumbar discectomy (PELD) and unilateral biportal endoscopic (UBE) discectomy in the treatment of far lateral lumbar disc herniation (FLLDH): a retrospective study
Journal of Orthopaedic Surgery and Research 2025cited by 10position: firstdoi
STK3 is a transcriptional target of YAP1 and a hub component in the crosstalk between Hippo and Wnt signaling pathways during gastric carcinogenesis
Molecular Cancer 2025cited by 10position: middledoi
An innovative minimally invasive technique for lumbar adjacent segment disease: a retrospective comparative analysis between extreme-oblique lumbar interbody fusion combined with percutaneous endoscopic lumbar discectomy(XOLIF-PELD) and posterior lumbar interbody fusion(PLIF) revision
Journal of Orthopaedic Surgery and Research 2025cited by 3position: middledoi
High humidity environment increases FBG by impairing the intestinal barrier
Frontiers in Immunology 2025cited by 1position: middledoi
DeepPMD: A Comprehensive Deep Learning Framework for Primary-Metastatic Classification and Origin Prediction in Lung Adenocarcinoma – Multi-Center Whole Slide Image Validation
Research Square 2025cited by 0position: firstdoi
Cancer‐associated fibroblasts potentiate colorectal cancer progression by crosstalk of the <scp>IGF2</scp>–<scp>IGF1R</scp> and <scp>Hippo–YAP1</scp> signaling pathways
The Journal of Pathology 2022cited by 42position: middledoi
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract
Cancer Communications 2022cited by 30position: middledoi
An RNA–RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity
Signal Transduction and Targeted Therapy 2021cited by 97position: middledoi
Relationship Between Lifestyle Habits and Health-Related Quality of Life of Recently Diagnosed Breast Cancer Patients: A Comparison Between Younger and Older Women in China
Frontiers in Public Health 2021cited by 10position: middledoi
Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention
The Oncologist 2017cited by 48position: middledoi
A case-control study on risk factors of breast cancer in Han Chinese women
Oncotarget 2017cited by 34position: middledoi
Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment‐naïve Chinese patients: Analysis of results from the CONSENT trial
Diabetes Obesity and Metabolism 2017cited by 26position: middledoi
Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors
Journal of Clinical Oncology 2016cited by 265position: middledoi
PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma
Tumor Biology 2016cited by 16position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chenglong Zhao · Southern Medical University3 papers (2025–2025)Jinbang Li · Jiangsu University3 papers (2025–2025)Jiabo Ma · Huazhong University of Science and Technology3 papers (2025–2025)Yingxue Xu · Shandong University of Traditional Chinese Medicine3 papers (2025–2025)Hao Chen · Northeastern University3 papers (2025–2025)Wei Zhang · Hebei Medical University2 papers (2025–2025)Jiguang Wang · Columbia University2 papers (2025–2025)Anjia Han · Qingdao University2 papers (2025–2025)Cheng Jin · University of Electronic Science and Technology of China2 papers (2025–2025)Zhenhui Li · South China Agricultural University2 papers (2025–2025) · 2 papers (2025–2025)Yapeng Sun · Hebei Medical University2 papers (2025–2025)Lei Guo · Hebei Medical University2 papers (2025–2025)Jilong An · Hebei Medical University2 papers (2025–2025)Yueping Liu · Hebei Medical University2 papers (2022–2025)Fengtao Zhou · Chongqing University2 papers (2025–2025) · 2 papers (2025–2025)Xiuqi Shan · Hebei Medical University2 papers (2025–2025) · 2 papers (2025–2025)Zhiyong Liang · Affiliated Hospital of Guizhou Medical University1 papers (2022–2022)